Videos | In the state of Mato Grosso, Brazil, patients and experts talk about the pain and consequences of living with leishmaniasis, a neglected disease.
A video, documentary journalistic series produced for the Drugs for Neglected Diseases initiative (DNDi) in Latin America, a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected diseases. The videos were used with the organization’s social media strategy and platforms.
350 million people in 98 countries are at risk of contracting leishmaniasis, a disease caused by Leishmania, transmitted by sandflies. Although there is some progress in drug development, especially for visceral leishmaniasis (also known as kala-azar), current drugs remain expensive, toxic, difficult to administer, or ill-suited for use in remote areas. There is a lack of adequate treatment in Africa and Latin America. While there are some treatments recommended by WHO, sustainable access to treatment is not widely available in endemic countries.
A young mother struggles to access treatment, support and a better life for her family since burdened with cutaneous leishmaniasis.
João Lucas was only 8 months old when he was diagnosed with visceral leishmaniasis. This video is a tribute to his early-on struggles and a celebration of his successful treatment.
Moacir struggles with diffuse cutaneous leishmaniasis, a disease with horrific physical and psychological burdens, and the lack of available and accessible treatments for 25 years.
A young, working boy, almost loses his means and motivation when treating against visceral leishmaniasis, a fatal disease.